Slemmons KK - Search Results

1

A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Slemmons KK, Crose LES, Riedel S, Sushnitha M, Belyea B, Linardic CM. Slemmons KK, et al. Mol Cancer Res. 2017 Dec;15(12):1777-1791. doi: 10.1158/1541-7786.MCR-17-0004. Epub 2017 Sep 18. Mol Cancer Res. 2017. PMID: 28923841 Free PMC article.

2

Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.

Kephart JJ, Tiller RG, Crose LE, Slemmons KK, Chen PH, Hinson AR, Bentley RC, Chi JT, Linardic CM. Kephart JJ, et al. Among authors: slemmons kk. Clin Cancer Res. 2015 Nov 1;21(21):4868-80. doi: 10.1158/1078-0432.CCR-14-1797. Epub 2015 Jun 12. Clin Cancer Res. 2015. PMID: 26071485 Free PMC article.

3

Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma.

Conti B, Slemmons KK, Rota R, Linardic CM. Conti B, et al. Among authors: slemmons kk. Curr Drug Targets. 2016;17(11):1235-44. doi: 10.2174/1389450116666150907105756. Curr Drug Targets. 2016. PMID: 26343114 Review.

4

Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.

Slemmons KK, Crose LE, Rudzinski E, Bentley RC, Linardic CM. Slemmons KK, et al. PLoS One. 2015 Oct 23;10(10):e0140781. doi: 10.1371/journal.pone.0140781. eCollection 2015. PLoS One. 2015. PMID: 26496700 Free PMC article.

5

The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.

Deel MD, Slemmons KK, Hinson AR, Genadry KC, Burgess BA, Crose LES, Kuprasertkul N, Oristian KM, Bentley RC, Linardic CM. Deel MD, et al. Among authors: slemmons kk. Clin Cancer Res. 2018 Jun 1;24(11):2616-2630. doi: 10.1158/1078-0432.CCR-17-1207. Epub 2018 Mar 7. Clin Cancer Res. 2018. PMID: 29514840 Free PMC article.

6

A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling.

Slemmons KK, Deel MD, Lin YT, Oristian KM, Kuprasertkul N, Genadry KC, Chen PH, Chi JT, Linardic CM. Slemmons KK, et al. Biol Open. 2021 Feb 9;10(2):bio050211. doi: 10.1242/bio.050211. Biol Open. 2021. PMID: 33372065 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 34004824

8

Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.

Li JJ, Kovach AR, DeMonia M, Slemmons KK, Oristian KM, Chen C, Linardic CM. Li JJ, et al. Among authors: slemmons kk. Sci Rep. 2021 Aug 13;11(1):16505. doi: 10.1038/s41598-021-95355-2. Sci Rep. 2021. PMID: 34389744 Free PMC article.

9

Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.

Slemmons KK, Yeung C, Baumgart JT, Juarez JOM, McCalla A, Helman LJ. Slemmons KK, et al. Cancer Res. 2020 Jul 15;80(14):3046-3056. doi: 10.1158/0008-5472.CAN-19-3853. Epub 2020 Apr 30. Cancer Res. 2020. PMID: 32354737

10

Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas.

Darvishi E, Slemmons K, Wan Z, Mitra S, Hou X, Parmentier JH, Eddie Loh YH, Helman LJ. Darvishi E, et al. Neoplasia. 2020 Jul;22(7):274-282. doi: 10.1016/j.neo.2020.05.001. Epub 2020 May 25. Neoplasia. 2020. PMID: 32464274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters